Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer

U. De Giorgi, G. Rosti, G. Ciucci, B. Kopf, C. Minzi, M. Argnani, M. Marangolo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences